Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-31

Clinical Trial Update: Uninterrupted Clopidogrel Therapy Before Elective Colonoscopy Will Increase the Risk of Post-polypectomy Bleeding [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial found that continuing clopidogrel uninterrupted before elective colonoscopy increases the risk of post-polypectomy bleeding.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Gastrointestinal Bleeding | Phase 4 | Status: COMPLETED